09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency -> Adult -> Clinical Studies

A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, Open‑Label Study

Presenter:
  • L. Snyder
Session Number
C15
Session Title:
C15 - PREDICTING OUTCOMES IN COPD
Session Type:
Mini Symposium
Authors
  • L. Snyder
  • G. Safioti
  • M. Reich
  • M. Neely
  • N. Lugogo
  • R. Pleasants
  • T. Li
  • L. Granovsky
  • M. DePietro
Video Upload

Previous Eposter
FOOTPRINTS® Study Methodology and Baseline Characteristics: A 3-Year Longitudinal Study to Phenotype Patients with COPD

Next Eposters
Biomarkers to Predict Forced Expiratory Volume in 1 Second (FEV1) Decline in Healthy Smokers and Early-Onset Chronic Obstructive Pulmonary Disease (COPD)
GDF-15, Pentraxin-3 and TIMP-1 Plasma Biomarkers Improve Risk Assessment for Mortality in Ambulatory Veterans with COPD
Cardiovascular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Chronic Obstructive Pulmonary Disease (COPD): A 24-Hour Holter Monitoring Sub-Study of the ETHOS Trial
Chronic Obstructive Pulmonary Disease Plus (COPD+)® as a Friendly App for Patients with Chronic Obstructive Pulmonary Disease
Insights from Mid-Expiratory Flow Rate (FEF25-75%) in Ever-Smokers with Preserved Lung Function in the Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) Cohort
Club Cell Protein-16 (CC16) Is Reduced in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Relationship of Dorsal Hyperkyphosis with Quality of Life in Patients with COPD in Northeastern Colombia
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations
Extracellular Vesicle-Derived Muscle-Specific miRNAs for the Characterization of Group B COPD Patients
Exploring the Patient Experience of Chronic Cough and Mucus in COPD Using Qualitative Methods